PRLog - Nov. 11, 2012 - NEW YORK -- According to a paper published in the journal PLoS One entitled, A Survey of the FDA’s AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class, “Cholesterol management drugs known as statins are widely used and often well tolerated; however, a variety of muscle-related side effects can arise. These adverse events (AEs) can have serious impact, and form a significant barrier to therapy adherence.”
Muxscle helps prevent muscle problems associated with statin use.
Muscle related side effects include muscle weakness as well as muscle aches and pains.
The paper reported that “Relative risk rates for rosuvastatin were consistently higher than other statins. Atorvastatin (Lipitor) and simvastatin showed intermediate risks, while pravastatin and lovastatin appeared to have the lowest risk rates.”
Statins such as Lipitor are a class of drugs used by patients to lower their cholesterol levels.
The best-selling statin is, in fact, Lipitor, manufactured by Pfizer. In 2003, Lipitor became the best-selling pharmaceutical in history. Currently, there are many statins on the market, including atorvastatin (Lipitor and Torvast), fluvastatin (Lescol), lovastatin (Mevacor, Altocor, Altoprev), pitavastatin (Livalo, Pitava), pravastatin (Pravachol, Selektine, Lipostat), rosuvastatin (Crestor) and simvastatin (Zocor, Lipex).
The CBCD suggests that patients taking Lipitor, and that are at risk of developing muscle weakness as a side effect, consider also taking Muxscle.
Muxscle is a dietary supplement that increases physical strength by stimulating the signal that nerves send to muscles. Muxscle has been clinically tested by scientists at the Center for the Biology of Chronic Disease (CBCD). The scientists found that it safely increased the overall physical strength of the participants in the study. They also found that it improved those daily activities that required the use of physical strength. The study is currently awaiting publication in scientific journals.
An abstract of the scientific study is available on the CBCD website at http://www.cbcd.net/
Those who have a hard time fully understanding the science and terminologies in the CBCD reports should show them to their doctor. A print-ready copy of the abstract is available at http://www.cbcd.net/
A website that includes information about Muxscle written for the general public is available at http://www.muxscle.com.
Hoffman KB, Kraus C, Dimbil M, Golomb BA A Survey of the FDA’s AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class. PLoS One. 2012
John S. Boyd, Ph.D.
The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net)
The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.